The influence of acetylsalicylic acid intake by healthy volunteers on duplicate PFA-100 measurements

被引:7
作者
Gunnewiek, JMTK
Hovestad-Witterland, AHI
Vollaard, EJ
Fleuren, HWHA
de Metz, M
机构
[1] Canisius Wilhelmina Hosp, Dept Clin Chem, NL-6500 GS Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp, Dept Clin Pharmacol, NL-6500 GS Nijmegen, Netherlands
关键词
PFA-100; aspirin; acetylsalicylic acid; reproducibility;
D O I
10.1097/01.mbc.0000172099.04040.93
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The PFA-100 device is increasingly used for assessing platelet function. Its use to monitor anti-platelet therapy, like acetylsalicylic acid (ASA), has been described. In most studies single PFA-100 measurements were used. In this study, we evaluate the influence of ASA on duplicate measurements using collagen/epinephrine cartridges. Twelve healthy volunteers received a single dose of 160 mg ASA and 12 other healthy volunteers received 30 mg ASA during 10 days followed by 80 mg ASA during 10 days. PFA-100 measurements were performed in duplicate 1 and 24 h after the final intake of medication. The mean coefficient of variation of duplicate measurements before medication was 8.4% and at least two times higher after the intake of a single dose of 160 mg ASA or 30 mg ASA during 10 days. Per individual, huge differences between duplicate measurements were observed after ASA ingestion. Differences were less pronounced after ingestion of 80 mg ASA during 10 days, because six of 12 volunteers had a maximum PFA-100 value > 300 s in both measurements. As a consequence, one should be cautious to use the PFA-100 to monitor ASA therapy in individual patients.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 19 条
[1]   Antiplatelet effect of aspirin in patients with cerebrovascular disease [J].
Alberts, MJ ;
Bergman, DL ;
Molner, E ;
Jovanovic, BD ;
Ushiwata, I ;
Teruya, J .
STROKE, 2004, 35 (01) :175-178
[2]   Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease [J].
Andersen, K ;
Hurlen, M ;
Arnesen, H ;
Seljeflot, I .
THROMBOSIS RESEARCH, 2002, 108 (01) :37-42
[3]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[4]   MECHANISMS OF PLATELET ACTIVATION - THROMBOXANE-A2 AS AN AMPLIFYING SIGNAL FOR OTHER AGONISTS [J].
FITZGERALD, GA .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (07) :B11-B15
[5]   HUMAN PLATELET ERYTHROLEUKEMIA CELL PROSTAGLANDIN G/H SYNTHASE - CDNA CLONING, EXPRESSION, AND GENE CHROMOSOMAL ASSIGNMENT [J].
FUNK, CD ;
FUNK, LB ;
KENNEDY, ME ;
PONG, AS ;
FITZGERALD, GA .
FASEB JOURNAL, 1991, 5 (09) :2304-2312
[6]   Aspirin non-responder status in patients with recurrent cerebral ischemic attacks [J].
Grundmann, K ;
Jaschonek, K ;
Kleine, B ;
Dichgans, J ;
Topka, H .
JOURNAL OF NEUROLOGY, 2003, 250 (01) :63-66
[7]   Profile and prevalence of aspirin resistance in patients with cardiovascular disease [J].
Gum, PA ;
Kottke-Marchant, K ;
Poggio, EC ;
Gurm, H ;
Welsh, PA ;
Brooks, L ;
Sapp, SK ;
Topol, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :230-235
[8]   Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100(TM) system [J].
Heilmann, EJ ;
Kundu, SK ;
Sio, R ;
Garcia, C ;
Gomez, R ;
Christie, DJ .
THROMBOSIS RESEARCH, 1997, 87 (01) :159-164
[9]   DEVELOPMENT OF ASPIRIN RESISTANCE IN PERSONS WITH PREVIOUS ISCHEMIC STROKE [J].
HELGASON, CM ;
BOLIN, KM ;
HOFF, JA ;
WINKLER, SR ;
MANGAT, A ;
TORTORICE, KL ;
BRACE, LD .
STROKE, 1994, 25 (12) :2331-2336
[10]   Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100® [J].
Homoncik, M ;
Jilma, B ;
Hergovich, N ;
Stohlawetz, P ;
Panzer, S ;
Speiser, W .
THROMBOSIS AND HAEMOSTASIS, 2000, 83 (02) :316-321